Skip to content
  • Tuesday, 29 September 2026
  • 10:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Part 2: Is Your Laboratory Really Ready?
Laboratory Safety & Compliance

Part 2: Is Your Laboratory Really Ready?

Layla Zulfa Sep 28, 2026 0

Preparing for the arrival of a highly infectious disease (HID) within a clinical laboratory setting requires a transition from reactive…

Read More
Laboratory Safety & Compliance

Part 2: Is Your Laboratory Really Ready?

Layla Zulfa Sep 21, 2026 0

Preparing for the arrival of highly infectious diseases requires a paradigm shift in how clinical laboratories assess operational risk, moving…

Read More
Environmental & Analytical Chemistry

Repetition Really Matters: Elbow Writing Study Reveals the Power of Practice in Skill Acquisition

Abdurrohim Arsyad Jul 14, 2026 0

The common understanding of human motor skill development has long acknowledged a natural, innate preference for using one side of…

Read More
Neuroscience & Brain Research

Scientists May Have Found What Really Triggers Alzheimer’s Disease

Rifan Muazin Jun 19, 2026 0

A groundbreaking study from the University of California, Riverside, suggests that the traditional understanding of Alzheimer’s disease may require a…

Read More
The oral exposure challenge in PROTACs: What drug developers need to solve earlyMeditation and Intensive Mind-Body Practices Produce Rapid Measurable Changes in Brain Connectivity and Blood Biology According to New ResearchGene Therapy Breakthrough Offers Non-Addictive Path for Chronic Pain Treatment via Brain-Specific Circuit TargetingCavidi AB’s BOLD Technology Sets New Standards in Immunoassay Sensitivity and Precision for Biomedical Research and Diagnostics
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ